- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ADPM
Total 1264 results
-
Tianjin Huanhu HospitalRecruiting
-
Royal Marsden NHS Foundation TrustRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomAstraZeneca; Cancer Research UKRecruitingGynaecological CancersUnited Kingdom
-
University of UtahClovis Oncology, Inc.Terminated
-
Mario Negri Institute for Pharmacological ResearchNorth Eastern German Society of Gynaecological OncologyActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaItaly, Germany
-
Dana-Farber Cancer InstituteTesaro, Inc.Active, not recruiting
-
Matthew GalskyIcahn School of Medicine at Mount Sinai; AstraZenecaCompletedMetastatic Urothelial CancerUnited States
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
PfizerTerminated
-
UNICANCERClovis Oncology, Inc.; Fondation ARCCompletedMetastatic Breast CancerFrance
-
AstraZenecaNo longer availablePSR Ovarian Cancer With a BRCA MutationJapan
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownNon Small Cell Lung CancerFrance
-
Dana-Farber Cancer InstituteWithdrawnOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Institut Paoli-CalmettesGlaxoSmithKlineNot yet recruiting
-
Nader SanaiGlaxoSmithKline; University of California, San Francisco; Barrow Neurological... and other collaboratorsRecruitingGlioma | Glioblastoma | Glioblastoma Multiforme | GBM | Glioma, Malignant | Glioblastoma Multiforme of BrainUnited States
-
Massachusetts General HospitalTesaro, Inc.RecruitingTriple Negative Breast Cancer | Residual DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingOral Squamous Cell Carcinoma (OSCC)United States
-
Richard ZellarsCompleted
-
Beth Israel Deaconess Medical CenterJohns Hopkins University; Dana-Farber Cancer Institute; AstraZenecaActive, not recruitingMetastatic Breast Cancer | Invasive Breast Cancer | BRIP1 Gene Mutation | PALB2 Gene Mutation | ATM Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | Somatic Mutation Breast Cancer (BRCA1) | Somatic Mutation Breast Cancer (BRCA2)United States
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedBreast NeoplasmsSweden, United States, United Kingdom, Germany, Spain, Australia, Israel, Canada
-
Allarity TherapeuticsDanish Breast Cancer Cooperative Group; Smerud Medical Research International...Active, not recruiting
-
University of Michigan Rogel Cancer CenterActive, not recruitingProstate CancerUnited States
-
zr Pharma & GmbHCompletedAdvanced Solid TumorJapan
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island HospitalTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United KingdomCompleted
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
PfizerMedivation, Inc.CompletedAcute Myeloid Leukemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic SyndromeUnited Kingdom, United States
-
University of MalayaMinistry of Education, MalaysiaCompletedDepression | Mood Disorders | Depressive Symptoms | Depressive Disorder, MajorMalaysia
-
University Hospital, GrenobleTerminatedKidney Failure, Chronic | Hypertension Resistant to Conventional TherapyFrance
-
Massachusetts General HospitalGlaxoSmithKlineRecruitingMetastatic Cancer | Central Nervous System CancerUnited States
-
Spanish Breast Cancer Research GroupAstraZenecaCompleted
-
AstraZenecaActive, not recruitingBreast | Prostate | Ovarian | Pancreatic | Advanced TumoursSweden, Spain, Israel, Australia, Germany
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Haihe Biopharma Co., Ltd.TerminatedBreast Cancer | Ovarian Cancer | Solid Tumor | Prostate Cancer | Endometrial CancerUnited States, Australia, China
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate AdenocarcinomaUnited States
-
GlaxoSmithKlineSuspendedNeoplasmsGermany, Spain, United Kingdom, France, Hungary, Czechia
-
Sarah E TaylorAmerican Society of Clinical OncologyTerminatedOvarian CancerUnited States
-
Arcagy ResearchBelgian Gynaecological Oncology Group; Grupo Español de Investigación en Cáncer... and other collaboratorsCompletedOvarian CancerFrance, Germany, Austria, Denmark, Italy, Japan, Finland, Spain, Monaco, Sweden, Belgium
-
AbbVieNo longer availableHigh Grade Serous Ovarian Cancer | Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound | Triple Negative Breast Cancer (TNBC) | Patients Requiring Veliparib Suspension Formulation
-
Grupo Español de Investigación en Cáncer de OvarioCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerSpain
-
National Cancer Institute (NCI)Completed
-
University Hospital, CaenCompleted
-
National Cancer Institute (NCI)CompletedAdvanced Breast Cancer | Advanced Solid Tumors | Primary Peritoneal Cancer | Advanced Ovarian CancerUnited States
-
Jihong LiuUnknownPlatinum-resistant Ovarian CancerChina
-
Laval UniversityTerminated
-
National Cancer Institute (NCI)CompletedBreast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal CancerUnited States
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustUnknownAdenocarcinoma of the ProstateUnited Kingdom
-
PfizerCompleted
-
Massachusetts General HospitalCompleted
-
Tesaro, Inc.WithdrawnLymphoma | Mantle-Cell